We focus on the elusive middle ground between tech & life science, and identify and invest in grounded, implementation-focused tech-powered startups that can improve how impactful new treatments are discovered, evaluated, and delivered.
We are interested in solutions that:
- Apply technology to a relevant pharma business problem.
- Have founders with deep domain expertise in tech and pharma.
- Focus on pragmatic implementation (vs tech development).
Some general investment categories we are looking at include:
- Digital biology: target identification, lead generation, imaging.
- Clinical evidence: siteless trials, data fusion, phenotyping.
- Patient engagement: empowerment, education, digital tx.
If any of the above applies to your work, please get in touch!
I work with Emory Data Science and Technology (DST), an initiative to connect students, researchers, clinicians, engineers, and data scientists across Emory and Georgia Tech so they can solve medical problems.
Our team is creating four initiatives:
- Seminar and journal club focused on AI in medicine.
- Weekly newsletter covering the latest relevant papers, industry activity, and local opportunities.
- Think Tank event to catalyze projects and collaboration.
- Database of projects for faculty, trainees, and students.
In 2014 I co-founded Forge, a non-profit that provided startups with funding, mentors, and assistance with clinical pilots. In 2016 Forge merged with Sling Health, a biomedical technology incubator with a national presence (see blog post).
At Emory I created an elective course for medical students on Innovation & Entrepreneurship in Medicine and ran it for two years.
At UCLA I founded and led a chapter of the International Society for Pharmaceutical Engineering. We were the first organization to provide students with career opportunities in biotechnology and pharma.